THIRD AMENDED AND RESTATED NOTE PURCHASE AGREEMENTNote Purchase Agreement • September 9th, 2024 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 9th, 2024 Company Industry JurisdictionTHIS THIRD AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of September 9, 2024 (the “Amendment Effective Date”), is entered into by and among CYCLO THERAPEUTICS, INC., a Nevada corporation (the “Company”), and RAFAEL HOLDINGS, INC., a Delaware corporation (the “Investor”).